• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number MICL 13.7
Device Problems Misfocusing (1401); Inadequacy of Device Shape and/or Size (1583)
Patient Problems Glaucoma (1875); Intraocular Pressure Increased (1937); Blurred Vision (2137); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
A4 - unk.A5 - unk.A6 - unk.B3 - unk.D2 - product code: unk (esubmitter software does not allow for a blank or 'unk' entry).D4 - unk.H4 - unk.H6- health effect impact code 4581: pigment dispersion, iris atrophy.Claim#(b)(4).
 
Event Description
The reporter indicated that the surgeon implanted a 13.7mm micl13.7, implantable collamer lens into the patient's left eye (os) on (b)(6)2017.The lens was explanted due to permanent loss of bcva, elevated iop 38mmhg without pupil block and angle closure(assesed on (b)(6)2023), pigment dispersion, blurred vision, iris atrophy, and excessive vault on (b)(6)2023.Addition of new pi, yag, performed on (b)(6)2017.This did not resolved the problem.Cause of the event is reported as device.Lens possibly too large.Iridotomy was not done per charge review.Lpi done 9 months post-op.
 
Manufacturer Narrative
Corrected data: b5- the reporter indicated the surgeon implanted an 13.7mm micl 13.7 implantable collamer lens into the patient's left eye (os) on (b)(6) 2017.The patient experienced glaucoma, excessive vault, permanent loss of bcva, elevated iop, pigment dispersion, blurred vision, iris atrophy, zonular laxity, significant reduction of iridocorneal angles, yag was performed, and medication was prescribed.On (b)(6) 2023 the lens was explanted but the problem was not resolved.Status of eye: "some zonular laxity noted at surgery.Has glaucomatous optic neuropathy with iop controlled on timilol." additional information provided: "icl saved for analysis by staar and confirmation of size/power.Rt visian icl subsequently removed and kdb goniotomy performed on (b)(6) 2023".The reporter indicated the cause of the event was the device.Cause details provided: " lens possibly too large, w excessive vault, pigment dispersion.Preop iridoctomy was not done per chart review.Had lpi done 9 months post op".H6- health effect- clinical code: 4581- "significant reduction of iridocorneal angles" and "zonular laxity" should be added.H6- health effect- clinical code: "1875" should be added.H6-health effect- impact code: "4644" should be added.Claim# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
joselene muniz
1911 walker avenue
monrovia, CA 91016
MDR Report Key17119687
MDR Text Key317129036
Report Number2023826-2023-02156
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMICL 13.7
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2023
Initial Date FDA Received06/13/2023
Supplement Dates Manufacturer Received11/17/2023
Supplement Dates FDA Received11/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNK.
Patient Outcome(s) Required Intervention;
Patient SexMale
-
-